Abstract
Odevixibat (Bylvay (TM); Bylvay (R)) has been approved for progressive familial intrahepatic cholestasis (PFIC) in patients aged >= 3 months in the......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
